Consumer Cyclical
SK3 Group, Inc.(SKTO)
Live Price
Offline$0.00001
+0.00% today
1Y Change
-50.00%
Window
Jun 23, 2025 → Jun 9, 2026
- Market Cap
- —
- Revenue Growth
- 0.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 0.0%
Coverage: 242 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SK3 Group, Inc. (SKTO) is a Consumer Cyclical stock with listed on OTC. The stock last traded around $0.00 and down 50.0% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 50.2% and ROIC 66.7%. Valuation is more restrained than many high-expectation growth names at P/E 0.0 and price/sales 0.0. Stock Foundry combines SKTO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.5% peer median
Operating Margin
Above sector median
+50.2% vs +8.4% peer median
P/E
Below sector median
0.0 vs 18.1 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 50.2%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKTO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SKTO Max Drawdown
-50.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SKTO and SPY.
Company Overview
SK3 Group, Inc.
Other OTC
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. The company was formerly known as CTT International Distributors, Inc. and changed its name to SK3 Group, Inc. in May 2007. The company was founded in 2000 and is headquartered in Los Angeles, California. SK3 Group, Inc. is a subsidiary of Healthcare of Today, Inc.
- Leadership
- Artemus Mayor
- IPO Date
- May 15, 2008
- Employees
- 15
- Street Address
- 448 South Hill Street
- Mailing
- Los Angeles, CA, 90013
- Region
- Los Angeles, CA, US
- Reporting Currency
- USD
- Investor Line
- 305-423-7144
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 0.0
- EV/EBITDA
- 0.0
- Price/Sales
- 0.0
- Price/Book
- 0.0
Growth
- Revenue
- 0.0%
- EPS
- 0.0%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 99.9%
- Operating Margin
- 50.2%
- Net Margin
- 32.1%
- ROE
- 133.4%
- ROIC
- 66.7%
Balance Sheet
- Debt/Equity
- 0.02
- Current Ratio
- 10.04
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.